The apoC-IV Activators chemical class encapsulates a range of compounds identified for their potential role in modulating the activity of apoC-IV, a protein primarily involved in the intricate processes of lipid metabolism and lipoprotein regulation. This diverse group of molecules, characterized by their different mechanisms of action, is unified by the hypothesized common outcome of influencing lipid metabolic pathways, which could indirectly impact the functionality of apoC-IV. The class includes fibrates like Fenofibrate and Gemfibrozil, recognized for their ability to activate peroxisome proliferator-activated receptor alpha (PPARα), a key regulator in lipid metabolism. The action of these compounds is believed to result in modifications of lipid processing or transport pathways where apoC-IV plays a crucial role. Additionally, the inclusion of Omega-3 Fatty Acids and Nicotinic Acid reflects their known roles in modulating lipoprotein metabolism, which might intersect with apoC-IV's regulatory functions in lipid processing and transport.
Further extending this class are PPARγ agonists such as Pioglitazone and Rosiglitazone, chosen for their involvement in lipid metabolism adjustments, particularly in relation to glucose homeostasis and insulin sensitivity. These compounds are thought to indirectly affect apoC-IV's activity by altering lipid metabolic processes. Statins, including Atorvastatin, and cholesterol absorption inhibitors like Ezetimibe, are also part of this category. Their role in cholesterol metabolism is hypothesized to influence apoC-IV's function due to the intertwined nature of cholesterol and lipid metabolism. Moreover, natural compounds like Polyphenols, Berberine, Green Tea Extract, and Curcumin have been included for their reported impacts on lipid metabolic pathways. Through various mechanisms, ranging from antioxidant properties to direct modulation of metabolic enzymes, these compounds are proposed to exert broad effects on the regulatory roles of proteins like apoC-IV. Collectively, the apoC-IV Activators represent a thoughtfully assembled group of compounds, each with the potential to indirectly modulate the complex network of lipid metabolism, highlighting the intricate interplay between diverse biochemical pathways and key regulatory proteins such as apoC-IV.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
As a fibrate, it can activate PPARα, potentially influencing lipid metabolism processes involving apoC-IV. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Another fibrate that activates PPARα, potentially modulating lipid pathways involving apoC-IV. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
A PPARγ agonist, could indirectly affect lipid metabolism pathways related to apoC-IV. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Similar to Pioglitazone, as a PPARγ agonist, it might influence apoC-IV activity in lipid metabolism. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
A statin that influences cholesterol metabolism, potentially affecting apoC-IV-related pathways. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Known to modulate lipid metabolism, could indirectly influence apoC-IV activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Contains compounds that affect lipid metabolism, potentially impacting apoC-IV. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Has been shown to influence lipid metabolism, possibly affecting apoC-IV's role in this process. | ||||||